Delivery Order SPE2DB22D3009-SPE2DB24FAJ45

Award Date 11/17/23
Potential Completion Date 11/20/23
Potential Value $2.8K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,139.52, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract covers the delivery of Erythromycin 0.5% eye ointment 3.5 grams and has an ultimate completion date of December 28, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., also known as Amerisourcebergen....
This federal contract award, valued at $3,140.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.5% Erythromycin eye ointment, a medical product used for the treatment of eye infections. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $2,462.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Erythromycin 0.5% Eye Ointment, 3.5 grams, to support military healthcare programs. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,674.12, is for the delivery of Erythromycin 0.5% eye ointment. The award has an ultimate completion date of October 24, 2023 and is structured as a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as...
This federal contract award is for the delivery of Erythromycin 0.5% eye ointment, 3.5 grams, to the Defense Logistics Agency (DLA). The contract, valued at $1,266.59, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $1,266.59 and an ultimate completion date of December 11, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract has no set-aside designation, indicating full and open...
This federal contract award is for the delivery of 4,566,765,471 units of Erythromycin 0.5% Eye Ointment in 3.5 gram containers. The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 19, 2024 with a completion date of December 20, 2024. The contract has a firm fixed price of $6,296.24 and was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency that supports military healthcare...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4565253700 - Erythromycin 0.5% Eye Ointment, with a ceiling value of $2,307.34 and a completion date of July 26, 2024. This appears to be a delivery order placed under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and...
This federal contract award is for the delivery of Erythromycin 0.5% eye ointment to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,114.95 and a completion date of December 8, 2023. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of ERYTHROMYCIN 0.5% EYE OINTMENT, a pharmaceutical product, with a ceiling value of $4,571.36. The contract type is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of January 28, 2025. The contract award was made on January 27, 2025 and does not...
This federal contract award is for the delivery of Erythromycin 0.5% eye ointment, 3.5 grams, to the Defense Logistics Agency (DLA). The $1,536.56 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply...
  • SPE2DB22D3009
    Indefinite Delivery Contract
  • SPE2DB22D3009-SPE2DB24FAJ45
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Erythromycin 0.5% eye ointment. The award has a ceiling value of $2,822.73 and a completion date of November 20, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, is the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award was made through open competition and does not have a set-aside designation.

Generated 5/12/25, 9:43 AM